Company Profile

Thuris Corporation
Profile last edited on: 8/14/07      CAGE: 09YT2      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1996
First Award
2004
Latest Award
2004
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

101 Theory Drive Suite 250
Irvine, CA 92612
   (949) 417-4623
   khoffman@thuris.com
   www.thuris.com
Location: Single
Congr. District: 45
County: Orange

Public Profile

Thuris is focused on pharmaceuticals to treat select Orphan and niche indications in-house, ranging from ischemia-related conditions, brain inflammation, and Huntington's disease. The future pursuit of Alzheimer's disease and Mild Cognitive Impairment will be in alliance with pharmaceutical partners

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2004 1 NIH $235,528
Project Title: Kinase Inhibitors against Neurodegeneration

Key People / Management

  Gary S Lynch -- President

Company News

There are no news available.